What is the current Price Target for the Immunovant Inc stock?

The average Immunovant Inc target price is $47.94. This is 31.78% higher than the current stock price. The highest price target is 90.49%, the lowest is -16.71%. 18 Analysts have issued a price target Immunovant Inc 2027 .

How high will the Immunovant Inc stock rise?

No reliable answer can be given as to how high the Immunovant Inc stock will rise. The performance of stocks, including the Immunovant Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Immunovant Inc stock today?

The performance of Immunovant Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Immunovant Inc stock fall?

The decline in Immunovant Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Immunovant Inc Forecast, price target & analysts

$36.38

0.74%

Nasdaq, Sep 16, 04:00 pm EDT.

ISIN

US45258J1025

Symbol

IMVT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Immunovant Inc Target price 2026 - Analyst rating & recommendation

Immunovant Inc Classifications & Recommendation

Buy

78%

Hold

22%

Immunovant Inc Price Target

Target Price	$47.94
Price	$36.38
Potential	31.78% register free of charge
Number of Estimates	18

	18 Analysts have issued a price target Immunovant Inc 2027 . The average Immunovant Inc target price is $47.94. This is 31.78% register free of charge higher than the current stock price. The highest price target is $69.30 90.49% register free of charge , the lowest is $30.30 16.71% register free of charge .
	A rating was issued by 23 analysts: 18 Analysts recommend Immunovant Inc to buy, 5 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Immunovant Inc stock has an average upside potential 2027 of 31.78% register free of charge . Most analysts recommend the Immunovant Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2033

Create a premium account to unlock analyst estimates. Learn more

Annually

	Mar '26	2027 Estimates
Earnings Per Share $	-2.77	-2.97
	1.47%	7.22%
P/E		negative

17 Analysts have issued a Immunovant Inc forecast for earnings per share. The average Immunovant Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2026. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2026	$-2.77	1.47%
2027	$-2.97 7.22% unlock
2028	$-2.89 2.69% unlock
2029	$-2.24 22.49% unlock
2030	$2.96 232.14% unlock
2031	$4.44 50.00% unlock
2032	$5.70 28.38% unlock
2033	$7.13 25.09% unlock

Current	-13.94	125.12%
2027	-12.24 12.19% unlock
2028	-12.60 2.94% unlock
2029	-16.22 28.73% unlock
2030	12.30 175.83% unlock
2031	8.20 33.33% unlock
2032	6.38 22.20% unlock
2033	5.10 20.06% unlock

Immunovant Inc...

Current Immunovant Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
JP Morgan	Locked ➜ Locked	Locked	Aug 04 2026
Citigroup	Locked ➜ Locked	Locked	Jun 30 2026
Guggenheim	Locked ➜ Locked	Locked	May 26 2026
Truist Securities	Locked ➜ Locked	Locked	May 22 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	May 21 2026
B of A Securities	Locked ➜ Locked	Locked	May 21 2026
Goldman Sachs	Locked ➜ Locked	Locked	Apr 15 2026

Analyst Rating	Date
Locked JP Morgan: Locked ➜ Locked	Aug 04 2026
Locked Citigroup: Locked ➜ Locked	Jun 30 2026
Locked Guggenheim: Locked ➜ Locked	May 26 2026
Locked Truist Securities: Locked ➜ Locked	May 22 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	May 21 2026
Locked B of A Securities: Locked ➜ Locked	May 21 2026
Locked Goldman Sachs: Locked ➜ Locked	Apr 15 2026

Discover more stocks with a high price target

NIO ADR 104.57%

Alibaba Group Holding Ltd 75.49%

Infineon 67.84%

Rheinmetall 61.11%

Tencent Holdings Ltd. 60.42%

TUI 53.54%

Siemens Energy 52.49%

Adyen 47.20%

Uber Technologies 45.16%

Adidas 44.20%

NVIDIA 43.06%

BYD 41.55%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now